Literature DB >> 16809443

Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids.

Pauline M Jamieson1, Chien Li, Christina Kukura, Joan Vaughan, Wylie Vale.   

Abstract

The endogenous corticotropin-releasing factor (CRF) type 2 receptor (CRFR2)-selective ligand urocortin 3 is expressed in discrete subcortical brain regions with fibers distributed mainly to hypothalamic and limbic structures. Close anatomical association between major urocortin 3 terminal fields and CRFR2 in hypothalamus, lateral septum, and medial amygdala (MEA) suggest it is well placed to modulate behavioral and hormonal responses to stress. Urocortin 3 was administered intracerebroventricularly to male rats under basal conditions or before a restraint stress, and circulating ACTH, corticosterone, glucose, and insulin were measured. Urocortin 3 activated the hypothalamic-pituitary-adrenal axis under basal conditions and augmented ACTH responses to restraint stress. Elevated blood glucose with lowered insulin to glucose ratios in both groups suggested increased sympathetic activity. Circulating catecholamines were also increased by urocortin 3, providing additional evidence for sympathoadrenomedullary stimulation. Intracerebroventricular urocortin 3 increased vasopressin mRNA expression in the parvocellular division of the hypothalamic paraventricular nucleus, whereas CRF expression was unchanged, providing a possible mechanism by which urocortin 3 mediates its actions. Urocortin 3 mRNA expression was examined after exposure to stress-related paradigms. Restraint increased levels in MEA with a trend to increased expression in the rostral perifornical hypothalamic area, whereas hemorrhage and food deprivation decreased expression in MEA. Adrenalectomy markedly increased expression in the rostral perifornical hypothalamic area, and high-level corticosterone replacement restored this to control levels. The evidence that urocortin 3 has the potential to influence hormonal components of the stress response and the changes in its expression levels after stressors is consistent with a potential function for the endogenous peptide in modulating stress responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809443     DOI: 10.1210/en.2006-0545

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.

Authors:  Yael Kuperman; Orna Issler; Limor Regev; Ifat Musseri; Inbal Navon; Adi Neufeld-Cohen; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

2.  Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Authors:  William J Giardino; Gregory P Mark; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.

Authors:  Hongxia Chao; Michael Digruccio; Peilin Chen; Chien Li
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

4.  Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.

Authors:  W J Giardino; R Pastor; A M J Anacker; E Spangler; D M Cote; J Li; M P Stenzel-Poore; T J Phillips; A E Ryabinin
Journal:  Genes Brain Behav       Date:  2010-09-30       Impact factor: 3.449

5.  Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain.

Authors:  Peilin Chen; David Lin; Jessica Giesler; Chien Li
Journal:  J Comp Neurol       Date:  2011-07-01       Impact factor: 3.215

6.  Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.

Authors:  Peilin Chen; Joan Vaughan; Cindy Donaldson; Wylie Vale; Chien Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-01       Impact factor: 4.310

7.  Oxytocin in the nucleus accumbens shell reverses CRFR2-evoked passive stress-coping after partner loss in monogamous male prairie voles.

Authors:  Oliver J Bosch; Joanna Dabrowska; Meera E Modi; Zachary V Johnson; Alaine C Keebaugh; Catherine E Barrett; Todd H Ahern; JiDong Guo; Valery Grinevich; Donald G Rainnie; Inga D Neumann; Larry J Young
Journal:  Psychoneuroendocrinology       Date:  2015-11-23       Impact factor: 4.905

8.  Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA.

Authors:  E M Fekete; Y Zhao; C Li; V Sabino; W W Vale; E P Zorrilla
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

9.  Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice.

Authors:  Amanda L Sharpe; Tamara J Phillips
Journal:  Behav Pharmacol       Date:  2009-07       Impact factor: 2.293

10.  Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat.

Authors:  Takeshi Nakamura; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.